BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23076703)

  • 1. Treatment of Stargardt disease with dobesilate.
    Cuevas P; Outeiriño LA; Angulo J; Giménez-Gallego G
    BMJ Case Rep; 2012 Oct; 2012():. PubMed ID: 23076703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal dobesilate in the treatment of choroidal neovascularisation associated with age-related macular degeneration: report of two cases.
    Cuevas P; Outeiriño L; Azanza C; Giménez-Gallego G
    BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 22948997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durable recovery of the macular architecture and functionality of a diagnosed age-related macular degeneration 1 year after a single intravitreal injection of dobesilate.
    Cuevas P; Outeiriño LA; Azanza C; Giménez-Gallego G
    BMJ Case Rep; 2013 Nov; 2013():. PubMed ID: 24225910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of dry age-related macular degeneration with dobesilate.
    Cuevas P; Outeiriño LA; Angulo J; Giménez-Gallego G
    BMJ Case Rep; 2012 Jun; 2012():. PubMed ID: 22729337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective lipid transport and biosynthesis in recessive and dominant Stargardt macular degeneration.
    Molday RS; Zhang K
    Prog Lipid Res; 2010 Oct; 49(4):476-92. PubMed ID: 20633576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dobesilate in the treatment of plaque psoriasis.
    Cuevas P; Arrazola JM
    Eur J Med Res; 2005 Sep; 10(9):373-6. PubMed ID: 16183548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic cystoid macular oedema treated with intravitreal dobesilate.
    Cuevas P; Outeiriño LA; Angulo J; Giménez-Gallego G
    BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22778475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy.
    Cuevas P; Outeiriño LA; Azanza C; Angulo J; Giménez-Gallego G
    Eur J Med Res; 2012 Jul; 17(1):22. PubMed ID: 22788836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-onset stargardt disease: phenotypic and genotypic characteristics.
    Lambertus S; van Huet RA; Bax NM; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
    Ophthalmology; 2015 Feb; 122(2):335-44. PubMed ID: 25444351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapeutics for Stargardt disease.
    Lu LJ; Liu J; Adelman RA
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1057-1062. PubMed ID: 28285324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal imaging and multifocal electroretinography demonstrate autosomal recessive Stargardt disease may present like occult macular dystrophy.
    Sisk RA; Leng T
    Retina; 2014 Aug; 34(8):1567-75. PubMed ID: 24743636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.
    Schönbach EM; Wolfson Y; Strauss RW; Ibrahim MA; Kong X; Muñoz B; Birch DG; Cideciyan AV; Hahn GA; Nittala M; Sunness JS; Sadda SR; West SK; Scholl HPN;
    JAMA Ophthalmol; 2017 Jul; 135(7):696-703. PubMed ID: 28542693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic response of rosacea to dobesilate.
    Cuevas P; Arrazola JM
    Eur J Med Res; 2005 Oct; 10(10):454-6. PubMed ID: 16287608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of basal cell carcinoma with dobesilate.
    Cuevas P; Arrazola JM
    J Am Acad Dermatol; 2005 Sep; 53(3):526-7. PubMed ID: 16112368
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcium dobesilate (Cd) in pigmented purpuric dermatosis (PPD): a pilot evaluation.
    Agrawal SK; Gandhi V; Bhattacharya SN
    J Dermatol; 2004 Feb; 31(2):98-103. PubMed ID: 15160862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.
    Haritoglou C; Gerss J; Sauerland C; Kampik A; Ulbig MW;
    Lancet; 2009 Apr; 373(9672):1364-71. PubMed ID: 19376452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INSIGHTS INTO AUTOSOMAL DOMINANT STARGARDT-LIKE MACULAR DYSTROPHY THROUGH MULTIMODALITY DIAGNOSTIC IMAGING.
    Palejwala NV; Gale MJ; Clark RF; Schlechter C; Weleber RG; Pennesi ME
    Retina; 2016 Jan; 36(1):119-30. PubMed ID: 26110599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELLIPSOID ZONE MAPPING AND OUTER RETINAL ASSESSMENT IN STARGARDT DISEASE.
    Arepalli S; Traboulsi EI; Ehlers JP
    Retina; 2018 Jul; 38(7):1427-1431. PubMed ID: 28613213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into autofluorescence patterns in Stargardt macular dystrophy using ultra-wide-field imaging.
    Kumar V
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1917-1922. PubMed ID: 28689222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration, distribution, and elimination of remofuscin/soraprazan in Stargardt mouse eyes following a single intravitreal injection using pharmacokinetics and transmission electron microscopic autoradiography: Implication for the local treatment of Stargardt's disease and dry age-related macular degeneration.
    Julien-Schraermeyer S; Illing B; Tschulakow A; Taubitz T; Guezguez J; Burnet M; Schraermeyer U
    Pharmacol Res Perspect; 2020 Dec; 8(6):e00683. PubMed ID: 33164337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.